Mar
Hernández-Guillamon

Dr. Mar Hernández-Guillamon has dedicated her career to the study of Aβ-associated pathologies, including AD and cerebral amyloid angiopathy. This career direction started in 2000 during her PhD studies in the Biochemistry Department of the Neuroscience Institute, Universitat Autónoma de Barcelona, Spain. During her postdoctoral fellowship in the Neurovascular Research Lab of Vall d’Hebron Research Institute, Barcelona, she consolidated her experience in the neuroscience field and established her knowledge in clinical neurology. Part of her postdoctoral training was at the Pathology Department of the New York University (Langone Medical Center, New York City), where she studied the involvement of cellular proteases in the degradation of Aβ peptides. In 2012, she was awarded the Miguel Servet grant from the Spanish government to start her own research group, which is the Cerebral Amyloid Angiopathy laboratory at the Vall d’Hebron Research Institute, Barcelona.